GlaxoSmithKline Files Lawsuit Against Lek
Ljubljana, 13 November - The pharmaceutical multinational GlaxoSmithKline has filed a lawsuit with a U.S. court against Slovenia's drug maker Lek for pattern violation, a Slovenian business daily reports on Wednesday. According to Finance, GlaxoSmithKline is suing Lek because of Lek's antibiotic Amoksiklav, a generic version of Glaxo's blockbuster drug Augmentin.
The rest of this news item is available to subscribers.
The news item consists of 1.028 characters (without spaces) or 194 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.